The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Mesenchymal Stem Cells Cooperate with Bone Marrow Cells in Therapy of Diabetes
Abstract
Several recent studies have suggested that the adult bone marrow harbors cells that can influence β-cell regeneration in diabetic animals. Other reports, however, have contradicted these findings. To address this issue, we used an animal model of type 1 diabetes in which the disease was induced with streptozotocin in mice. Freshly prepared sex-mismatched bone marrow cells (BMCs) and syngeneic or allogeneic mesenchymal stem cells (MSCs) were concomitantly administrated into sublethally irradiated diabetic mice. Blood glucose and serum insulin concentrations rapidly returned to normal levels, accompanied by efficient tissue regeneration after a single injection of a mixture of 106 BMCs per 105 MSCs. Neither BMC nor MSC transplantation was effective alone. Successful treatment of diabetic animals was not due to the reconstitution of the damaged islet cells from the transplant, since no donor-derived β-cells were found in the recovered animals, indicating a graft-initiated endogenous repair process. Moreover, MSC injection caused the disappearance of β-cell-specific T lymphocytes from diabetic pancreas. Therefore, we suggest that two aspects of this successful treatment regimen operate in parallel and synergistically in our model. First, BMCs and MSCs induce the regeneration of recipient-derived pancreatic insulin-secreting cells. Second, MSCs inhibit T-cell-mediated immune responses against newly formed β-cells, which, in turn, are able to survive in this altered immunological milieu. Thus, the application of this therapy in human patients suffering from diabetes and/or other tissue destructive autoimmune diseases may be feasible. Disclosure of potential conflicts of interest is found at the end of this article.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human mesenchymal stem cells modulate allogeneic immune cell responses
Aggarwal, S., & Pittenger, M. F. (2005) · Blood · doi:10.1182/blood-2004-04-1559 · Cited by 4,511
Mesenchymal stem cells as trophic mediators
Caplan, A. I., & Dennis, J. E. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20886 · Cited by 2,992
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734
Bartholomew, A., Sturgeon, C., Siatskas, M., Ferrer, K., McIntosh, K., Patil, S., Hardy, W., Devine, S., Ucker, D., Deans, R., et al. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(01)00769-x · Cited by 2,295
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
Herold, K. C., Hagopian, W., Auger, J. A., Poumian-Ruiz, E., Taylor, L., Donaldson, D., Gitelman, S. E., Harlan, D. M., Xu, D., Zivin, R. A., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012864 · Cited by 1,222
Autologous mesenchymal stem cell transplantation in stroke patients
Bang, O. Y., Lee, J. S., Lee, P. H., & Lee, G. (2005) · Annals of Neurology · doi:10.1002/ana.20501 · Cited by 1,102
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes
Keymeulen, B., Vandemeulebroucke, E., Ziegler, A. G., Mathieu, C., Kaufman, L., Hale, G., Gorus, F., Goldman, M., Walter, M., Candon, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043980 · Cited by 1,099
Induction of Pancreatic Differentiation by Signals from Blood Vessels
Lammert, E., Cleaver, O., & Melton, D. (2001) · Science · doi:10.1126/science.1064344 · Cited by 1,050
Peister, A., Mellad, J. A., Larson, B. L., Hall, B. M., Gibson, L. F., & Prockop, D. J. (2004) · Blood · doi:10.1182/blood-2003-09-3070 · Cited by 994
Streptozotocin-Induced Pancreatic Insulitis: New Model of Diabetes Mellitus
Like, A. A., & Rossini, A. A. (1976) · Science · doi:10.1126/science.180605 · Cited by 979
Bone Marrow–Derived Mesenchymal Stem Cells in Repair of the Injured Lung
Rojas, M., Xu, J., Woods, C. R., Mora, A. L., Spears, W., Roman, J., & Brigham, K. L. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0330oc · Cited by 848
Review: Mesenchymal Stem Cells: Cell–Based Reconstructive Therapy in Orthopedics
Caplan, A. I. (2005) · Tissue Engineering · doi:10.1089/ten.2005.11.1198 · Cited by 822
Ianus, A., Holz, G. G., Theise, N. D., & Hussain, M. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16502 · Cited by 772
Lee, R. H., Seo, M. J., Reger, R. L., Spees, J. L., Pulin, A. A., Olson, S. D., & Prockop, D. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608249103 · Cited by 710
Bone marrow–derived stem cells initiate pancreatic regeneration
Hess, D., Li, L., Martin, M., Sakano, S., Hill, D., Strutt, B., Thyssen, S., Gray, D. A., & Bhatia, M. (2003) · Nature Biotechnology · doi:10.1038/nbt841 · Cited by 614
Seaberg, R. M., Smukler, S. R., Kieffer, T. J., Enikolopov, G., Asghar, Z., Wheeler, M. B., Korbutt, G., & van der Kooy, D. (2004) · Nature Biotechnology · doi:10.1038/nbt1004 · Cited by 557
Immunoregulatory function of mesenchymal stem cells
Uccelli, A., Moretta, L., & Pistoia, V. (2006) · European Journal of Immunology · doi:10.1002/eji.200636416 · Cited by 557
β cell replication is the primary mechanism for maintaining postnatal β cell mass
Georgia, S. K., & Bhushan, A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422098 · Cited by 506
RASMUSSON, I., RINGDEN, O., SUNDBERG, B., & LEBLANC, K. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.12.013 · Cited by 493
Generating green fluorescent mice by germline transmission of green fluorescent ES cells
Hadjantonakis, A.-K., Gertsenstein, M., Ikawa, M., Okabe, M., & Nagy, A. (1998) · Mechanisms of Development · doi:10.1016/s0925-4773(98)00093-8 · Cited by 483
Le Blanc, K., & Ringdén, O. (2005) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2005.01.005 · Cited by 471
Immune modulation by mesenchymal stem cells
Rasmusson, I. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.03.019 · Cited by 374
Islet Regeneration During the Reversal of Autoimmune Diabetes in NOD Mice
Kodama, S., Kühtreiber, W., Fujimura, S., Dale, E. A., & Faustman, D. L. (2003) · Science · doi:10.1126/science.1088949 · Cited by 355
No Evidence for Significant Transdifferentiation of Bone Marrow Into Pancreatic β-Cells In Vivo
Lechner, A., Yang, Y.-G., Blacken, R. A., Wang, L., Nolan, A. L., & Habener, J. F. (2004) · Diabetes · doi:10.2337/diabetes.53.3.616 · Cited by 251
Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta cells
Choi, J. B., Uchino, H., Azuma, K., Iwashita, N., Tanaka, Y., Mochizuki, H., Migita, M., Shimada, T., Kawamori, R., & Watada, H. (2003) · Diabetologia · doi:10.1007/s00125-003-1182-9 · Cited by 241
Prospective Isolation of Multipotent Pancreatic Progenitors Using Flow-Cytometric Cell Sorting
Suzuki, A., Nakauchi, H., & Taniguchi, H. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2143 · Cited by 218
Neural transdifferentiation of mesenchymal stem cells – a critical review
KRABBE, C., ZIMMER, J., & MEYER, M. (2005) · APMIS · doi:10.1111/j.1600-0463.2005.apm_3061.x · Cited by 214
Beta-cell differentiation from nonendocrine epithelial cells of the adult human pancreas
Hao, E., Tyrberg, B., Itkin-Ansari, P., Lakey, J. R. T., Geron, I., Monosov, E. Z., Barcova, M., Mercola, M., & Levine, F. (2006) · Nature Medicine · doi:10.1038/nm1367 · Cited by 214
Regenerative and immunomodulatory potential of mesenchymal stem cells
KRAMPERA, M., PASINI, A., PIZZOLO, G., COSMI, L., ROMAGNANI, S., & ANNUNZIATO, F. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.02.008 · Cited by 177
Cyclosporine A and adverse effects on organs: histochemical studies
Rezzani, R. (2004) · Progress in Histochemistry and Cytochemistry · doi:10.1016/j.proghi.2004.04.001 · Cited by 170
Recruitment of Bone Marrow-Derived Endothelial Cells to Sites of Pancreatic β-Cell Injury
Mathews, V., Hanson, P. T., Ford, E., Fujita, J., Polonsky, K. S., & Graubert, T. A. (2004) · Diabetes · doi:10.2337/diabetes.53.1.91 · Cited by 168
Paik, S., Fleischer, N. L., & Shin, S. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.10.6129 · Cited by 163
Deng, W., Han, Q., Liao, L., et al. (2005) · DNA and Cell Biology · doi:10.1089/dna.2005.24.458 · Cited by 153
Mesenchymal Stem Cells and the Treatment of Cardiac Disease
Minguell, J. J., & Erices, A. A. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100105 · Cited by 148
Streptozotocin Interactions with Pancreatic β Cells and the Induction of Insulin-Dependent Diabetes
Wilson, G. L., & Leiter, E. H. (1990) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-75239-1_3 · Cited by 142
Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy
Zimmet, J. M., & Hare, J. M. (2005) · Basic Research in Cardiology · doi:10.1007/s00395-005-0553-4 · Cited by 139
Horwitz, M. S., Ilic, A., Fine, C., Rodriguez, E., & Sarvetnick, N. (2002) · Journal of Clinical Investigation · doi:10.1172/jci11198 · Cited by 120
Reversal of Diabetes in Non-Obese Diabetic Mice Without Spleen Cell-Derived ß Cell Regeneration
Chong, A. S., Shen, J., Tao, J., Yin, D., Kuznetsov, A., Hara, M., & Philipson, L. H. (2006) · Science · doi:10.1126/science.1123510 · Cited by 110
Nishio, J., Gaglia, J. L., Turvey, S. E., Campbell, C. L., Benoist, C. O., & Mathis, D. J. (2006) · Science · doi:10.1126/science.1124004 · Cited by 110
Horwitz, M. S., Ilic, A., Fine, C., Rodriguez, E., & Sarvetnick, N. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0211198 · Cited by 110
Recovery of the Endogenous β Cell Function in the NOD Model of Autoimmune Diabetes
Zorina, T. D., Subbotin, V. M., Bertera, S., Alexander, A., Haluszczak, C., Gambrell, B., Bottino, R., Styche, A. J., & Trucco, M. (2003) · Stem Cells · doi:10.1634/stemcells.21-4-377 · Cited by 108
Immunological Reversal of Autoimmune Diabetes Without Hematopoietic Replacement of ß Cells
Suri, A., Calderón, B., Esparza, T. J., Frederick, K. E., Bittner, P., & Unanue, E. R. (2006) · Science · doi:10.1126/science.1123500 · Cited by 100
Reversal of experimental diabetes by multiple bone marrow transplantation
Banerjee, M., Kumar, A., & Bhonde, R. R. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.176 · Cited by 96
Complications Associated with Immunosuppressive Therapy and Their Management
Min, D. I., & Monaco, A. P. (1991) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1991.tb02641.x · Cited by 81
Dendritic Cells Expressing Transgenic Galectin-1 Delay Onset of Autoimmune Diabetes in Mice
Perone, M. J., Bertera, S., Tawadrous, Z. S., Shufesky, W. J., Piganelli, J. D., Baum, L. G., Trucco, M., & Morelli, A. E. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.5278 · Cited by 76
Repopulation of Human Pulmonary Epithelium by Bone Marrow Cells: A Potential Means to Promote Repair
Albera, C., Polak, J. M., Janes, S. M., Griffiths, M., Alison, M. R., Wright, N. A., Navaratnarasah, S., Poulsom, R., Jeffery, R. E., Fisher, C., et al. (2005) · Tissue Engineering · doi:10.1089/ten.2005.11.1115 · Cited by 74
Kang, E. M., Zickler, P., Burns, S., Langemeijer, S. M. C., Brenner, S., Phang, O. A., Patterson, N. B., Harlan, D. M., & Tisdale, J. F. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2005.03.008 · Cited by 60
Human Pancreatic Islet-Derived Progenitor Cell Engraftment in Immunocompetent Mice
Abraham, E. J., Kodama, S., Lin, J. C., Ubeda, M., Faustman, D. L., & Habener, J. F. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63170-7 · Cited by 47
β-cell proliferation is the major source of new pancreatic β cells
Dor, Y. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0187 · Cited by 38
How to make pancreatic β cells — prospects for cell therapy in diabetes
Nir, T., & Dor, Y. (2005) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2005.07.005 · Cited by 36
Stem cells and diabetes treatment
MADSEN, O. D. (2005) · Apmis · doi:10.1111/j.1600-0463.2005.apm_418.x · Cited by 27
Ta, M., Choi, Y., Atouf, F., Park, C. H., & Lumelsky, N. L. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0367 · Cited by 22
Rehabilitation of adaptive immunity and regeneration of beta cells
Pasquali, L., Fan, Y., Trucco, M., & Ringquist, S. (2006) · Trends in biotechnology · doi:10.1016/j.tibtech.2006.08.007 · Cited by 21
Potential application for mesenchymal stem cells in the treatment of cardiovascular diseases
Bunnell, B. A., Deng, W., Robinson, C., Waldron, P. R., Bivalacqua, T. J., Baber, S. R., Hyman, A. L., & Kadowitz, P. J. (2005) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y05-043 · Cited by 16
Cited by
Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications
Ghannam, S., Bouffi, C., Djouad, F., Jorgensen, C., & Noël, D. (2010) · Stem Cell Research & Therapy · doi:10.1186/scrt2 · Cited by 507
Mesenchymal Stem Cell-Based Immunomodulation: Properties and Clinical Application
Wang, M., Yuan, Q., & Xie, L. (2018) · Stem Cells International · doi:10.1155/2018/3057624 · Cited by 505
MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation
Kean, T. J., Lin, P., Caplan, A. I., & Dennis, J. E. (2013) · Stem Cells International · doi:10.1155/2013/732742 · Cited by 433
Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy
Glenn, J. D. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i5.526 · Cited by 406
Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress
Wu, X., Jiang, J., Gu, Z., Zhang, J., Chen, Y., & Liu, X. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01855-9 · Cited by 343
Metadata
- Authors
- Urbán, V. S., Kiss, J., Kovács, J., Gócza, E., Vas, V., Monostori, Ė., & Uher, F.
- Venue
- Stem Cells
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-10-11
- Volume
- 26
- Issue
- 1
- Pages
- 244-253
- ISSN
- 1066-5099 (ISSN-L)
- 1549-4918
- OpenAlex
- W2028174844
- Cited by
- 292
- References
- 54
- FWCI
- 21.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.